NeuroOne Medical Technologies Total Revenue

The latest total revenue for NMTC is $10M as of June 2026. That compares with $6.6M in the prior-year period — up 50.8% year over year. That is below the sector sector average of $1.3B. Investors often review this figure alongside NeuroOne Medical Technologies's historical trend and sector peers before judging valuation or financial health.

Over the past year, NMTC's total revenue moved from $6.6M to $10M — a 50.8% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in NeuroOne Medical Technologies's operating scale or balance-sheet position.

Against its sector companies, NMTC currently prints $10M for total revenue, while the sector average sits near $1.3B. That is roughly 99.3% below the sector mean. Large gaps often invite a closer look at NeuroOne Medical Technologies's growth, margins, and balance sheet.

A total revenue figure of $10M for NMTC is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $1.3B. Explore the charts below for those layers of context.

After noting NMTC's total revenue ($10M), review year-over-year change from $6.6M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.